Poly(glycerol sebacate)/gelatin core/shell fibrous structure for regeneration of myocardial infarction

Tissue Engineering - Part A

Volumn 17, Issue 9-10, 2011, Pages 1363-1373

  Ravichandran, Rajeswari ^a   Venugopal, Jayarama Reddy ^a   Sundarrajan, Subramanian ^a   Mukherjee, Shayanti ^a   Ramakrishna, Seeram ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION; BIOCOMPATIBILITY; BIOMECHANICS; CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; CONTACT ANGLE; ELECTROSPINNING; ENDOTHELIAL CELLS; FIBERS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GLYCEROL; HEART; MECHANICAL PROPERTIES; PROTEINS; SCANNING ELECTRON MICROSCOPY; STEM CELLS; TENSILE TESTING; TISSUE;

CARDIAC TISSUE ENGINEERING; CELL MORPHOLOGY; CORE/SHELL; FIBROUS STRUCTURES; GELATIN FIBERS; HEART FAILURE; HEART MUSCLES; IMMUNOFLUORESCENT STAINING; INDUSTRIALIZED NATIONS; MARKER PROTEINS; MESENCHYMAL STEM CELL; MYOCARDIAL INFARCTION; MYOCARDIAL TISSUE; PLATELET ENDOTHELIAL CELL ADHESION MOLECULES; POLY(GLYCEROL SEBACATE); SHELL MATERIALS; TROPONIN;

SCAFFOLDS (BIOLOGY);

DECANOIC ACID DERIVATIVE; DRUG DERIVATIVE; GELATIN; GLYCEROL; POLY(GLYCEROL SEBACATE); POLY(GLYCEROL-SEBACATE); POLYMER; TISSUE SCAFFOLD;

ANIMAL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; METABOLISM; METHODOLOGY; RABBIT; REGENERATION; TISSUE ENGINEERING;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; DECANOATES; GELATIN; GLYCEROL; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; POLYMERS; RABBITS; REGENERATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 79955031201     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0441     Document Type: Article

References (60)

1. Rosamond, W., Flegal, K., Furie, K., Go, A., Wilson, M., and Hong, Y. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117, 125, 2008.
2. Baig, M.K., Mahon, N., McKenna, W.J., Caforio, A.L.P., Bonow, R.O., Francis, G.S., and Gheorghiade, M. The pathophysiology of advanced heart failure. Heart Lung 28, 87, 1999.
3. Reinlib, L., and Field, L. Cell transplantation as future therapy for cardiovascular disease: a workshop of the National Heart, Lung, and Blood Institute. Circulation 101, 182, 2000.
4. Murry, C.E., Field, L.J., and Menasche, P. Cell-based cardiac repair: reflections at the 10-year point. Circulation 112, 3174, 2005.
5. Laflamme, M.A., and Murry, C.E. Regenerating the heart. Nat Biotechnol 23, 845, 2005.
6. Leor, J., Amsalem, Y., and Cohen, S. Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol Ther 105, 151, 2005.
7. Zimmermann, W.H., Melnychenko, I., and Eschenhagen, T. Engineered heart tissue for regeneration of diseased hearts. Biomaterials 25, 1639, 2004.
8. Etzion, S., Kedes, L.H., Kloner, R.A., and Leor, J. Myocardial regeneration: present and future trends. Am J Cardiovasc Drugs 1, 233, 2001.
9. Li, M., Guo, Y., Wei, Y., MacDiarmid, A.G., and Lelkes, P.I. Electrospinning polyaniline-contained gelatin nanofibers for tissue engineering applications. Biomaterials 27, 2705, 2006.
10. Taylor, D.A., Atkins, B.Z., Hungspreugs, P., Jones, T.R., Reedy, M.C., Hutchinson, K.A., Glower, D.D., and Kraus, W.E. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med 4, 929, 1998.
11. Li, R.K., Mickle, D.A.G., Weisel, R.D., Zhang, J., and Mohabeer, M.K. In vivo survival and function of transplanted rat cardiomyocytes. Circ Res 78, 283, 1996.
12. Peter Crapo, M., and Wang, Y. Physiologic compliance in engineered small-diameter arterial constructs based on an elastomeric substrate. Biomaterials 31, 1626, 2010.
13. Wang, Y., Ameer, G.A., Shappard, B.J., and Langer, R. A tough biodegradable elastomer. Nat Biotechnol 20, 602, 2002.
14. Chen, Q.Z., Bismarck, A., Hansen, U., Junaid, S., Tran, M.Q., Harding, S.E., Ali, N.N., and Boccaccini, A.R. Characterisation of a soft elastomer poly (glycerol sebacate) designed to match the mechanical properties of myocardial tissue. Biomaterials 29, 47, 2008.
15. Crapo, P.M., Gao, J., and Wang, Y. Seamless tubular poly (glycerol sebacate) scaffolds: high-yield fabrication and potential applications. J Biomed Mater Res A 86, 354, 2008.
16. Bettinger, C.J., Weinberg, E.J., Kulig, K.M., Vacanti, J.P., Wang, Y., Borenstein, J.T., and Langer, R. Three-dimensional microfluidic tissue-engineering scaffolds using a flexible biodegradable polymer. Adv Mater 18, 165, 2006.
17. Sundback, C.A., Shyu, J.Y., Wang, Y., Faquin, W.C., Langer, R.S., Vacanti, J.P., and Hadlock, T.A. Biocompatibility analysis of poly (glycerol sebacate) as a nerve guide material. Biomaterials 26, 5454, 2005.
18. Wang, Y., Kim, Y.M., and Langer, R. In vivo degradation characteristics of poly (glycerol sebacate). J Biomed Mater Res A 66, 192, 2002.
19. Wu, K.H., Mo, X.M., Liu, Y.L., Zhang, Y.S., and Han, Z.C. Stem cells for tissue engineering of myocardial constructs. Ageing Res Rev 67, 289, 2007.
20. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
21. Wakitani, S.T., Saito, T., and Caplan, A.I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18, 1417, 1995.
22. Makino, S., Fukuda, K., Miyoshi, S., Konishi, F., Kodama, H., Pan, J., Sano, M., Takahashi, T., Hori, S., Abe, H., Hata, J., Umezawa, A., and Ogawa, S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103, 705, 1999.
23. Kehat, I., Kenyagin-Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz-Eldor, J., and Gepstein, L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108, 414, 2001.
24. Hubbell, J.A. Materials as morphogenetic guides in tissue engineering. Curr Opin Biotechnol 14, 551, 2003.
25. Zong, X., Bien, H., Chiung-Yin Chung, Yin, L., Fang, D., Benjamin Hsiao, S., Chua, B., and Entcheva, E. Electrospun fine-textured scaffolds for heart tissue constructs. Biomaterials 26, 5330, 2005.
26. Pasquinelli, G., Orrico, C., Foroni, L., Bonafe, F., Carboni, M., Guarnieri, C., Raimondo, S., Penna, C., Geuna, S., Pagliaro, P., Freyrie, A., Stella, A., Caldarera, C.M., and Muscari, C. Mesenchymal stem cell interaction with a non-woven hyaluronan-based scaffold suitable for tissue repair. J Anat 213, 520, 2008.
27. Yoon, D.M., and Fisher, J.P. Polymeric scaffolds for tissue engineering applications. In: Bronzino, J.D., ed., Tissue Engineering. Boca Raton, FL: CRC Press, 2007, p. 81.
28. Heydarkhan-Hagvall, S., Schenke-Layland, K., Dhanasopon, A.P., Rofail, F., Smith, H., Wu, B.M., Shemin, R., Beygui, R.E., and MacLellan, W.R. Three-dimensional electrospun ECM-based hybrid scaffolds for cardiovascular tissue engineering. Biomaterials 29, 2907, 2008.
29. Zhang, S., Huang, Y., Yang, X., Mei, F., Ma, Q., Chen, G., Ryu, S., and Deng, X. Gelatin nanofibrous membrane fabricated by electrospinning of aqueous gelatin solution for guided tissue regeneration. J Biomed Mater Res A 90, 671, 2009.
30. Zhang, Y., Ouyang, H., Lim, C.T., Ramakrishna, S., and Huang, Z.M. Electrospinning of gelatin fibers and gelatin/ PCL composite fibrous scaffolds. J Biomed Mater Res B 72, 156, 2005.
31. Bordenave, L., Caix, J., Baquey, C., Midy, D., Baste, J.C., and Constans, H. Experimental evaluation of a gelatin-coated polyester graft used as an arterial substitute. Biomaterials 10, 235, 1989.
32. Ginalska, G., Kowalczuk, D., and Osinska, M. A chemical method of gentamicin bonding to gelatin-sealed prosthetic vascular grafts. Int J Pharm 288, 131, 2005.
33. Niu, S., Kurumatani, H., Satoh, S., Kanda, K., Oka, T., and Watanabe, K. Small diameter vascular prostheses with incorporated bioabsorbable matrices. A preliminary study. Am Soc Artif Intern Organs 39, 750, 1993.
34. Li, R.K., Jia, Z.Q., Weisel, R.D., Mickle, D.A., Choi, A., and Yau, T.M. Survival and function of bioengineered cardiac grafts. Circulation 100, II63, 1999.
35. Pasumarthi, K.B., and Field, L.J. Cardiomyocyte cell cycle regulation. Circ Res 90, 1044, 2002.
36. Zhang, Y.Z., Venugopal, J., Huang, Z.M., Lim, C.T., and Ramakrishna, S. Characterization of the surface biocompatibility of the electrospun PCL-Collagen nanofibers using fi- broblasts. Biomacromolecules 6, 2583, 2005.
37. Sadat, S., Gehmert, S., Song, Y.H., Yen, Y., Bai, X., Gaiser, S., Klein, H., and Alt, E. The cardioprotective effect of mesenchymal stem cells is mediated by IGF-I and VEGF. Biochem Biophys Res Commun 363, 674, 2007.
38. Amado, L.C., Schuleri, K.H., Saliaris, A.P., Boyle, A.J., Helm R., Oskouei, B., Centola, M., Eneboe, V., Young, R., Lima, J.A., Lardo, A.C., Heldman, A.W., and Hare, J.M. Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J Am Coll Cardiol 48, 2116, 2006.
39. Zimmermann, W.H., Melnychenko, I., Wasmeier, G., Didie, M., Naito, H., Nixdor, U., Hess, A., Budinsky, L., Brune, K., Michaelis, B., Dhein, S., Schwoerer, A., Ehmke, H., and Eschenhagen, T. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12, 452, 2006.
40. Minatoguchi, S., Takemura, G., Chen, X.H., Wang, N., Uno, Y., Koda, M., Arai, M., Misao, Y., Lu, C., Suzuki, K., Goto, K., Komada, A., Takahashi, T., Kosai, K., Fujiwara, T., and Fujiwara, H. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 109, 2572, 2004.
41. Dai, W., Hale, S.L., Kay, G.L., Jyrala, A.J., and Kloner, R.A. Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology. Regen Med 4, 387, 2009.
42. Chachques, J.C., Trainini, J.C., Lago, N., Masoli, O.H., Barisani, J.L., Cortes-Morichetti, M., Schussler, O., and Carpentier, A. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow-up. Cell Transplant 16, 927, 2007.
43. Xing, Y., Huang, P.J., and Zhang, K.M. Cardiac troponin T and I: application in myocardial injury and forensic medicine. Fa Yi Xue Za Zhi 19, 242, 2003.
44. Lemonnier, M., and Buckingham, M.E. Characterization of a cardiac-specific enhancer, which directs {alpha}-cardiac actin gene transcription in the mouse adult heart. J Biol Chem 279, 55651, 2004.
45. Brand, N.J., Roy, A., Hoare, G., Chester, A., and Yacoub, M.H. Cultured interstitial cells from human heart valves express both specific skeletal muscle and non-muscle markers. Int J Biochem Cell Biol 38, 30, 2006.
46. Parmacek, M.S., and Solaro, R.J. Biology of the troponin complex in cardiac myocytes. Prog Cardiovasc Dis 47, 159, 2004.
47. Tan, M.Y., Zhi, W., Wei, R.Q., Huang, Y.C., Zhou, K.P., and Tan, B. Repair of infracted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 30, 3234, 2009.
48. Engler, A.J., Sen, S., Sweeney, H.L., and Discher, D.E. Matrix elasticity directs stem cell lineage specification. Cell 126, 677, 2006.
49. Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S.M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D.M., Leri, A., and Anversa, P. Bone marrow cells regenerate infarcted myocardium. Nature 410, 701, 2001.
50. Toma, C., Pittenger, M.F., Cahill, K.S., Byrne, B.J., and Kessler, P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93, 2002.
51. Mangi, A.A., Noiseux, N., Kong, D.L., He, H.M., Rezvani, M., and Ingwall, J.S. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9, 1195, 2003.
52. Pittenger, M.F., and Martin, B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95, 9, 2004.
53. Piao, H., Youn, T.J., Kwon, J.S., Kim, Y.H., Bae, J.W., Bora, S., Kim, D.W., Cho, M.C., Lee, M.M., and Park, Y.B. Effects of bone marrow derived mesenchymal stem cells transplantation in acutely infracting myocardium. Eur J Heart Fail 7, 730, 2005.
54. Robinson, K.A., Li, J., Mathison, M., Redkar, A., Cui, J., Chronos, N.A.F., and Mathenyl R.G. Extracellular matrix scaffold for cardiac repair. Circulation 112, 135, 2005.
55. Terada, N., Hamazaki, T., Oka, M., Hoki, M., Mastalerz, D.M., Nakano, Y., Meyer, E.M., Morel, L., Petersen, B.E., and Scott, E.W. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 416, 542, 2002.
56. Yang, Y.J., Qian, H.Y., Huang, J., Li, J.J., Gao, R.L., Dou, K.F., Yang, G.S., Willerson, J.T., and Geng, Y.J. Combined therapy with simvastatin and bone marrow derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arterioscler Thromb Vasc Biol 29, 2076, 2009.
57. Hackney, J.A., Charbord, P., Brunk, B.P., Stoeckert, C.J., Lemischka, I.R., and Moore, K.A. A molecular profile of a hematopoietic stem cell niche. Proc Natl Acad Sci USA 99, 13061, 2002.
58. Langer, R., and Tirrell, D.A. Designing materials for biology and medicine. Nature 428, 487, 2004.
59. Haider, H.K., and Ashraf, M. Strategies to promote donor cell survival: Combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol 45, 554, 2008.
60. Robey, T.E., Saiget, M.K., Reinecke, H., and Murry, C.E. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 45, 567, 2008.